Mylan NV (NASDAQ:MYL)

18.33
Delayed Data
As of Oct 18
 -0.55 / -2.91%
Today’s Change
16.63
Today|||52-Week Range
37.56
-33.10%
Year-to-Date
3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees
Oct 13 / MotleyFool.com - Paid Partner Content
Where Will Pfizer Be in 5 Years?
Sep 28 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Pfizer
Sep 29 / MotleyFool.com - Paid Partner Content
J&J's Prostate Cancer Drug Gets FDA Nod for Expanded Use
Sep 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.88
Today’s open18.88
Day’s range18.27 - 18.92
Volume6,171,894
Average volume (3 months)6,644,770
Market cap$9.7B
Data as of 3:59pm ET, 10/18/2019

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-6.37%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio305.5
Price/Sales1.24
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+2.90+3.54%
GLPGGalapagos NV-5.99-3.67%
BHCValeant Pharmaceutic...-0.26-1.14%
IONSIonis Pharmaceutical...-0.75-1.33%
Data as of 6:30pm ET, 10/18/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Hatfield, Hertfordshire

Forecasts